The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) hit a new 52-week high and has $56.38 target or 6.00% above today’s $53.19 share price. The 9 months bullish chart indicates low risk for the $1.03 billion company. The 1-year high was reported on Nov, 28 by Barchart.com. If the $56.38 price target is reached, the company will be worth $61.80 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 40,204 shares traded hands. Innophos Holdings, Inc. (NASDAQ:IPHS) has risen 50.13% since April 25, 2016 and is uptrending. It has outperformed by 44.11% the S&P500.
Analysts await Innophos Holdings, Inc. (NASDAQ:IPHS) to report earnings on February, 27. They expect $0.60 earnings per share, up 350.00% or $0.84 from last year’s $-0.24 per share. IPHS’s profit will be $11.62M for 22.16 P/E if the $0.60 EPS becomes a reality. After $0.75 actual earnings per share reported by Innophos Holdings, Inc. for the previous quarter, Wall Street now forecasts -20.00% negative EPS growth.
Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage
Out of 2 analysts covering Innophos Holdings (NASDAQ:IPHS), 1 rate it a “Buy”, 1 “Sell”, while 0 “Hold”. This means 50% are positive. Innophos Holdings has been the topic of 3 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The firm earned “Sell” rating on Monday, August 24 by Zacks. Sidoti initiated the shares of IPHS in a report on Thursday, October 20 with “Buy” rating. The firm has “Sell” rating given on Thursday, September 3 by Zacks.
According to Zacks Investment Research, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation.”
Insitutional Activity: The institutional sentiment increased to 1.3 in Q2 2016. Its up 0.08, from 1.22 in 2016Q1. The ratio improved, as 14 funds sold all Innophos Holdings, Inc. shares owned while 53 reduced positions. 30 funds bought stakes while 52 increased positions. They now own 17.50 million shares or 0.21% more from 17.46 million shares in 2016Q1.
Gotham Asset Mgmt Limited Liability Company last reported 0.08% of its portfolio in the stock. Blackrock Fund holds 1.26M shares or 0.01% of its portfolio. Manufacturers Life Ins The has 0% invested in the company for 13,233 shares. The North Carolina-based Wedge Management L Ltd Partnership Nc has invested 0% in Innophos Holdings, Inc. (NASDAQ:IPHS). Keeley Asset Mgmt holds 0.07% or 39,295 shares in its portfolio. Nationwide Fund Advsr holds 89,788 shares or 0.02% of its portfolio. Teton Advsr accumulated 7,000 shares or 0.03% of the stock. Moreover, Louisiana State Employees Retirement has 0.02% invested in Innophos Holdings, Inc. (NASDAQ:IPHS) for 8,600 shares. Toronto Dominion National Bank & Trust accumulated 13 shares or 0% of the stock. Blackrock holds 3,021 shares or 0% of its portfolio. Creative Planning last reported 0% of its portfolio in the stock. Bank Of America De owns 76,854 shares or 0% of their US portfolio. Motley Fool Wealth Mgmt Lc last reported 107,661 shares in the company. Public Sector Pension Investment Board owns 13,544 shares or 0.01% of their US portfolio. Rutabaga Cap Ma, a Massachusetts-based fund reported 65,229 shares.
Insider Transactions: Since September 9, 2016, the stock had 1 insider purchase, and 0 selling transactions for $40,310 net activity. Shares for $40,310 were bought by Zatta Robert J.
More important recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: Prnewswire.com which released: “Innophos Holdings, Inc. Reports Third Quarter 2016 Results” on October 27, 2016, also Prnewswire.com published article titled: “Innophos Holdings, Inc. Appoints Joshua Horenstein As Chief Legal Officer And …”, Prnewswire.com published: “Innophos Holdings, Inc. Appoints Han Kieftenbeld As Chief Financial Officer” on April 04, 2016. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) was released by: Prnewswire.com and their article: “Innophos Holdings, Inc. Reports First Quarter 2015 Results” with publication date: April 27, 2015.
IPHS Company Profile
Innophos Holdings, Inc., incorporated July 15, 2004, is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Firm also provides bioactive mineral and nutritional ingredients. The Company’s divisions include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other. The Specialty Phosphates US & Canada segment and Specialty Phosphates Mexico segment comprises product lines, such as Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA), and Technical Grade Sodium Tripolyphosphate (STPP) & Detergent Grade PPA. The GTSP & Other segment includes fertilizer co-product Granular Triple Super Phosphate (GTSP) and other non-specialty phosphate products. The Specialty Phosphates US & Canada segment and the Specialty Ingredients product line includes the activities of Innophos Nutrition, Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.